Evidence map›Paper›PMID 40486110›Full record

ArticleJHLT open2025

HOPE in every breath and heartbeat: Understanding transplant eligibility, access barriers, and clinical outcomes in thoracic transplantation in persons with HIV.

Patrick C K Tam, Julia A Messina, Bin Ni, Madeleine R Heldman, Julie M Steinbrink, John M Reynolds, Adam D DeVore, Arthur W Baker, Manuela Carugati, Ilan S Schwartz and 1 more

Abstract read
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patrick C K TamDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Julia A MessinaDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Bin NiDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Madeleine R HeldmanDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Julie M SteinbrinkDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
John M ReynoldsDepartment of Medicine, Transplant Pulmonology, Duke University School of Medicine, Durham, North Carolina.
Adam D DeVoreDuke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, NC, Durham, North Carolina.
Arthur W BakerDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Manuela CarugatiDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Ilan S SchwartzDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
Cameron R WolfeDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Persons with human immunodeficiency virus (PWH) are living longer, leading to increased end-organ disease from chronic illness. Organ transplantation improves survival in patients with end-organ disease yet remains a constrained resource due to limited access. We aimed to better understand barriers to transplantation for thoracic end-organ disease in PWH. Methods: We performed a retrospective study of patients referred to our center for consideration of thoracic organ transplant and assessed the factors associated with transplant eligibility in candidates with human immunodeficiency virus (HIV). We also assessed clinical outcomes in PWH progressing to transplant. Results: Over a 10-year period, 30 HIV-seropositive candidates and 10,905 HIV-seronegative candidates were referred to our center. Of candidates referred, 40% (12 of 30) of HIV-seropositive candidates were waitlisted compared to 20% (2,172 of 10,905) of HIV-seronegative candidates ( Conclusions: HIV-seropositive thoracic transplant candidates were more likely to be waitlisted compared to HIV-seronegative candidates. Progression to transplant and waitlist times were similar between candidates with and without HIV. Our study suggests that HIV alone was not a significant barrier to transplantation in PWH when referred and evaluated for thoracic organ transplantation.

Indexed as

cardiac transplantationHIV infectionHIV Organ Policy Equity Actlung transplantationPre-transplant evaluation

Identifiers

PMID40486110
PMCPMC12142534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.